These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 3902682

  • 1. Clobetasol propionate versus fluocinonide creams in psoriasis and eczema.
    Jegasothy B, Jacobson C, Levine N, Millikan L, Olsen E, Pinnell S, Cole G, Weinstein G, Porter M.
    Int J Dermatol; 1985 Sep; 24(7):461-5. PubMed ID: 3902682
    [Abstract] [Full Text] [Related]

  • 2. Clobetasol propionate ointment once daily versus fluocinonide ointment three times daily in psoriasis.
    Bickers D, Cornell R, Kamm AR, Bauman WE, Handler RM, Medansky RS, Sturm HM.
    Int J Dermatol; 1988 Sep; 27(1):54-5. PubMed ID: 3278991
    [No Abstract] [Full Text] [Related]

  • 3. Comparative efficacy of halcinonide and fluocinonide creams in psoriasis and eszematous dermatoses.
    Sudilovsky A, Clewe TH.
    J Clin Pharmacol; 1975 Sep; 15(11-12):779-84. PubMed ID: 1104668
    [Abstract] [Full Text] [Related]

  • 4. Fluocinonide compared with betamethasone in the treatment of eczema and psoriasis.
    Ronn HH.
    Practitioner; 1976 Jun; 216(1296):704-6. PubMed ID: 781661
    [Abstract] [Full Text] [Related]

  • 5. The efficacy of three class I topical synthetic corticosteroids, fluocinonide 0.1% cream, clobetasol 0.05% cream and halobetasol 0.05% cream: a Scholtz-Dumas bioassay comparison.
    Lee CS, Koo J.
    J Drugs Dermatol; 2009 Aug; 8(8):751-5. PubMed ID: 19663113
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of twice-daily augmented betamethasone dipropionate lotion versus clobetasol propionate solution in patients with moderate-to-severe scalp psoriasis.
    Katz HI, Lindholm JS, Weiss JS, Shavin JS, Morman M, Bressinck R, Cornell R, Pariser DM, Pariser RJ, Weng W.
    Clin Ther; 1995 Aug; 17(3):390-401. PubMed ID: 7585843
    [Abstract] [Full Text] [Related]

  • 7. Systemic effects of topical application of beclomethasone 17,21-dipropionate: comparative studies with betamethasone 17-valerate ointment and fluocinonide cream.
    Shimao S.
    J Dermatol; 1979 Dec; 6(6):383-90. PubMed ID: 396316
    [No Abstract] [Full Text] [Related]

  • 8. [Double-blind-study on treatment with clobetasol-17-propionate and other topical corticoids (author's transl)].
    Beck M, Berger C, Filipp N, Hundertmark U, Loewel R.
    Z Hautkr; 1981 Aug 15; 56(16):1066-70. PubMed ID: 7027655
    [Abstract] [Full Text] [Related]

  • 9. Intrinsic potencies of novel thiol ester corticosteroids RS-85095 and RS-21314 as compared with clobetasol 17-propionate and fluocinonide.
    Ong JT, Poulsen BJ, Akers WA, Scholtz JR, Genter FC, Kertesz DJ.
    Arch Dermatol; 1989 Dec 15; 125(12):1662-5. PubMed ID: 2589861
    [Abstract] [Full Text] [Related]

  • 10. A single-center, double-blind, randomized trial of the atrophogenic effects of fluocinonide cream 0.1% versus clobetasol propionate cream 0.05% in participants with corticosteroid-responsive dermatoses.
    Uliasz A, Zeichner J, Soung J, Wong V, Lebwohl M.
    Cutis; 2008 Jun 15; 81(6):517-9. PubMed ID: 18666395
    [Abstract] [Full Text] [Related]

  • 11. Multicenter study comparing 0.05% gel formulations of desoximetasone and fluocinonide in patients with scalp psoriasis.
    Willis I, Cornell RC, Penneys NS, Zaias N.
    Clin Ther; 1986 Jun 15; 8(3):275-82. PubMed ID: 3521856
    [Abstract] [Full Text] [Related]

  • 12. Adrenal suppression with high-potency corticosteroid ointment formulations in normal subjects.
    Novak E, Francom SF, Schlagel CA.
    Clin Ther; 1983 Jun 15; 6(1):59-71. PubMed ID: 6370438
    [Abstract] [Full Text] [Related]

  • 13. Multicenter trial of fluocinonide in an emollient cream base.
    Fisher M, Kelly AP.
    Int J Dermatol; 1979 Oct 15; 18(8):660-4. PubMed ID: 389843
    [Abstract] [Full Text] [Related]

  • 14. Treatment of psoriasis with amcinonide 0.1 percent and fluocinonide 0.05 percent ointments. A comparative double-blind study.
    Engel MF.
    Cutis; 1982 Jun 15; 29(6):646-50. PubMed ID: 7049592
    [Abstract] [Full Text] [Related]

  • 15. Therapy of infected dermatitis: comparative response to two corticosteroid antimicrobial creams.
    Wilkinson RD, Collins JP, Raymond GP, Mailhot R, Perras MA, Ricard P.
    J Am Acad Dermatol; 1980 Mar 15; 2(3):207-11. PubMed ID: 7364977
    [Abstract] [Full Text] [Related]

  • 16. Clinical experience with 0.05% clobetasol propionate creams.
    Richards RN.
    J Am Acad Dermatol; 1985 May 15; 12(5 Pt 1):891-3. PubMed ID: 4008693
    [No Abstract] [Full Text] [Related]

  • 17. Comparison of 0.25% desoxymethasone ointment with 0.05% fluocinonide ointment in psoriasis.
    Kuokkanen K.
    Curr Med Res Opin; 1985 May 15; 4(10):703-5. PubMed ID: 800971
    [Abstract] [Full Text] [Related]

  • 18. A randomized, double-blind, placebo-controlled study of clobetasol propionate 0.05% foam in the treatment of nonscalp psoriasis.
    Lebwohl M, Sherer D, Washenik K, Krueger GG, Menter A, Koo J, Feldman SR.
    Int J Dermatol; 2002 May 15; 41(5):269-74. PubMed ID: 12100701
    [Abstract] [Full Text] [Related]

  • 19. Superpotent topical steroid treatment of psoriasis vulgaris--clinical efficacy and adrenal function.
    Katz HI, Hien NT, Prawer SE, Mastbaum LI, Mooney JJ, Samson CR.
    J Am Acad Dermatol; 1987 Apr 15; 16(4):804-11. PubMed ID: 3553247
    [Abstract] [Full Text] [Related]

  • 20. [Comparative study of clobetasol dipropionate and betamethasone dipropionate].
    Rozzoni M, Tribbia G, Reseghetti A, Bassi R.
    G Ital Dermatol Venereol; 1982 Apr 15; 117(5):LXV-LXIX. PubMed ID: 6764916
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.